Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry.

Irvin MR, Sitlani CM, Noordam R, Avery CL, Bis JC, Floyd JS, Li J, Limdi NA, Srinivasasainagendra V, Stewart J, de Mutsert R, Mook-Kanamori DO, Lipovich L, Kleinbrink EL, Smith A, Bartz TM, Whitsel EA, Uitterlinden AG, Wiggins KL, Wilson JG, Zhi D, Stricker BH, Rotter JI, Arnett DK, Psaty BM, Lange LA.

Pharmacogenomics J. 2018 Jun 1. doi: 10.1038/s41397-018-0021-9. [Epub ahead of print]

PMID:
29855607
2.

Racial differences in statin adherence following hospital discharge for ischemic stroke.

Albright KC, Zhao H, Blackburn J, Limdi NA, Beasley TM, Howard G, Bittner V, Howard VJ, Muntner P.

Neurology. 2017 May 9;88(19):1839-1848. doi: 10.1212/WNL.0000000000003910. Epub 2017 Apr 12.

3.

Local Ancestry and Clinical Cardiovascular Events Among African Americans From the Atherosclerosis Risk in Communities Study.

Shendre A, Irvin MR, Wiener H, Zhi D, Limdi NA, Overton ET, Shrestha S.

J Am Heart Assoc. 2017 Apr 10;6(4). pii: e004739. doi: 10.1161/JAHA.116.004739.

4.

Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.

Harada S, Zhou Y, Duncan S, Armstead AR, Coshatt GM, Dillon C, Brott BC, Willig J, Alsip JA, Hillegass WB, Limdi NA.

Clin Pharmacol Ther. 2017 Sep;102(3):493-501. doi: 10.1002/cpt.631. Epub 2017 Jun 1. Review.

5.

US Mortality: Influence of Race, Geography and Cardiovascular Risk Among Participants in the Population-Based REGARDS Cohort.

Limdi NA, Howard VJ, Higginbotham J, Parton J, Safford MM, Howard G.

J Racial Ethn Health Disparities. 2016 Dec;3(4):599-607. Epub 2015 Nov 5.

6.

Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.

Ather S, Shendre A, Beasley TM, Brown T, Hill CE, Prabhu SD, Limdi NA.

Am J Cardiol. 2016 Jul 15;118(2):232-6. doi: 10.1016/j.amjcard.2016.04.047. Epub 2016 May 5.

7.

Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.

Limdi NA, Nolin TD, Booth SL, Centi A, Marques MB, Crowley MR, Allon M, Beasley TM.

Am J Kidney Dis. 2015 May;65(5):701-9. doi: 10.1053/j.ajkd.2014.11.004. Epub 2014 Nov 25.

8.

RYR3 gene variants in subclinical atherosclerosis among HIV-infected women in the Women's Interagency HIV Study (WIHS).

Shendre A, Irvin MR, Aouizerat BE, Wiener HW, Vazquez AI, Anastos K, Lazar J, Liu C, Karim R, Limdi NA, Cohen MH, Golub ET, Zhi D, Kaplan RC, Shrestha S.

Atherosclerosis. 2014 Apr;233(2):666-72. doi: 10.1016/j.atherosclerosis.2014.01.035. Epub 2014 Jan 30.

9.

Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.

Irvin MR, Shimbo D, Mann DM, Reynolds K, Krousel-Wood M, Limdi NA, Lackland DT, Calhoun DA, Oparil S, Muntner P.

J Clin Hypertens (Greenwich). 2012 Oct;14(10):694-700. doi: 10.1111/j.1751-7176.2012.00690.x. Epub 2012 Aug 3. Erratum in: J Clin Hypertens (Greenwich). 2018 Jun;20(6):1080.

10.

Preference-based quality-of-life measures for neocortical epilepsy surgery.

Knowlton RC, Kar J, Miller S, Limdi N, Elgavish R, Gilliam FG, Riley K, Howell J, Kilgore M.

Epilepsia. 2011 May;52(5):1018-20. doi: 10.1111/j.1528-1167.2011.03020.x. Epub 2011 Mar 22.

11.

Warfarin dosing in patients with impaired kidney function.

Limdi NA, Limdi MA, Cavallari L, Anderson AM, Crowley MR, Baird MF, Allon M, Beasley TM.

Am J Kidney Dis. 2010 Nov;56(5):823-31. doi: 10.1053/j.ajkd.2010.05.023. Epub 2010 Aug 14.

12.

Expectations, validity, and reality in pharmacogenetics.

Limdi NA, Veenstra DL.

J Clin Epidemiol. 2010 Sep;63(9):960-9. doi: 10.1016/j.jclinepi.2009.09.006. Epub 2009 Dec 7. Review.

13.

Effect of epilepsy magnetic source imaging on intracranial electrode placement.

Knowlton RC, Razdan SN, Limdi N, Elgavish RA, Killen J, Blount J, Burneo JG, Ver Hoef L, Paige L, Faught E, Kankirawatana P, Bartolucci A, Riley K, Kuzniecky R.

Ann Neurol. 2009 Jun;65(6):716-23. doi: 10.1002/ana.21660.

14.

Hyperammonemia following intravenous valproate loading.

DeWolfe JL, Knowlton RC, Beasley MT, Cofield S, Faught E, Limdi NA.

Epilepsy Res. 2009 Jul;85(1):65-71. doi: 10.1016/j.eplepsyres.2009.02.012. Epub 2009 Mar 18.

PMID:
19299111
15.

Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.

Limdi NA, Wiener H, Goldstein JA, Acton RT, Beasley TM.

Blood Cells Mol Dis. 2009 Jul-Aug;43(1):119-28. doi: 10.1016/j.bcmd.2009.01.019. Epub 2009 Mar 17.

16.

Kidney function influences warfarin responsiveness and hemorrhagic complications.

Limdi NA, Beasley TM, Baird MF, Goldstein JA, McGwin G, Arnett DK, Acton RT, Allon M.

J Am Soc Nephrol. 2009 Apr;20(4):912-21. doi: 10.1681/ASN.2008070802. Epub 2009 Feb 18.

17.

VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.

Limdi NA, Beasley TM, Crowley MR, Goldstein JA, Rieder MJ, Flockhart DA, Arnett DK, Acton RT, Liu N.

Pharmacogenomics. 2008 Oct;9(10):1445-58. doi: 10.2217/14622416.9.10.1445.

18.

Warfarin pharmacogenetics.

Limdi NA, Veenstra DL.

Pharmacotherapy. 2008 Sep;28(9):1084-97. doi: 10.1592/phco.28.9.1084. Review.

19.

Functional imaging: II. Prediction of epilepsy surgery outcome.

Knowlton RC, Elgavish RA, Bartolucci A, Ojha B, Limdi N, Blount J, Burneo JG, Ver Hoef L, Paige L, Faught E, Kankirawatana P, Riley K, Kuzniecky R.

Ann Neurol. 2008 Jul;64(1):35-41. doi: 10.1002/ana.21419.

PMID:
18570291
20.

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.

Limdi NA, Arnett DK, Goldstein JA, Beasley TM, McGwin G, Adler BK, Acton RT.

Pharmacogenomics. 2008 May;9(5):511-26. doi: 10.2217/14622416.9.5.511.

Supplemental Content

Loading ...
Support Center